PRESS RELEASE published on 02/28/2024 at 10:00, 2 years 2 months ago Karl Lauterbach visits Biotest AG's plasma donation centre in Cologne and emphasises important contribution to patient care Prof Dr Karl Lauterbach visits Biotest AG's plasma donation centre in Cologne, emphasizing vital contribution to patient care. Plasma donation in Germany crucial for medical supply Germany Patient Care Biotest AG Karl Lauterbach Plasma Donation
BRIEF published on 02/28/2024 at 10:00, 2 years 2 months ago Visit of Karl Lauterbach to the plasma donation center of Biotest AG in Cologne Germany Biotest AG Karl Lauterbach Plasma Donation Medical Care
PRESS RELEASE published on 02/14/2024 at 08:30, 2 years 2 months ago Biotest successfully meets primary endpoint in phase III trial with Fibrinogen concentrate Biotest successfully meets primary endpoint in phase III trial with Fibrinogen concentrate. Study results confirm safety profile & effectiveness equal to standard care in reducing blood loss. Biotest aims to address global medical need with USD 800 million market potential Biotest AG Fibrinogen Concentrate Phase III Trial Study Results Medical Market Potential
PRESS RELEASE published on 11/28/2023 at 09:00, 2 years 5 months ago EQS-News: Biotest’s Trimodulin shows reduced mortality in patients with severe community-acquired pneumonia through rapid normalisation of inflammation
PRESS RELEASE published on 11/02/2023 at 08:00, 2 years 5 months ago Biotest increases EBIT to Euro 125.4 million in the first nine months of 2023
PRESS RELEASE published on 10/05/2023 at 16:55, 2 years 6 months ago EQS-Adhoc: Biotest AG: Increase of the EBIT guidance
PRESS RELEASE published on 10/05/2023 at 16:42, 2 years 6 months ago EQS-Adhoc: Biotest AG: Peter Janssen appointed new Chairman of the Board of Biotest AG
PRESS RELEASE published on 09/21/2023 at 09:00, 2 years 7 months ago Biotest AG: Biotest receives approval for innovative immunoglobulin Yimmugo® in the UK
PRESS RELEASE published on 09/12/2023 at 09:00, 2 years 7 months ago Biotest AG: Biotest treats first patient with severe community-acquired pneumonia in phase III trial with trimodulin
PRESS RELEASE published on 09/07/2023 at 09:00, 2 years 7 months ago Biotest AG: US Food and Drug Administration FDA accepts marketing authorization application for immunoglobulin Yimmugo
Published on 05/01/2026 at 18:00, 2 hours 17 minutes ago Star Copper to Present at the Emerging Growth Conference on May 7, 2026
Published on 05/01/2026 at 15:35, 4 hours 42 minutes ago LNG Energy Group Announces Partial Revocation of Cease Trade Order and Proposed Private Placement
Published on 05/01/2026 at 14:00, 6 hours 17 minutes ago CCL Industries Closing of ALT Technologies Acquisition
Published on 05/01/2026 at 14:00, 6 hours 17 minutes ago Datavault AI and CyberCatch Announce Signing of Binding Letter of Intent for Datavault AI to Acquire CyberCatch to Accelerate AI-Driven, Quantum-Resistant Cyber Risk Mitigation Solutions
Published on 05/01/2026 at 13:01, 7 hours 16 minutes ago BeMetals Announces Resumption of Trading on TSX Venture Exchange and Effective Date of Share Consolidation
Published on 05/01/2026 at 19:23, 53 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 05/01/2026 at 17:45, 2 hours 31 minutes ago Burkhalter Group acquires Progressio Holding GmbH and anplaq ag, Tamins (GR)
Published on 05/01/2026 at 17:21, 2 hours 55 minutes ago Fuller, Smith & Turner PLC: Total Voting Rights and Treasury Shares
Published on 04/30/2026 at 19:16, 1 day 1 hour ago AXA announces the results of its Shareholders' Meeting
Published on 04/30/2026 at 19:00, 1 day 1 hour ago Capital increase through exercise of subscription rights
Published on 04/30/2026 at 18:10, 1 day 2 hours ago Minutes of the Combined General Meeting held on April 30, 2026